/PRNewswire/
April 11, 2024
BTL Industries, Inc., a leading provider of innovative medical aesthetic solutions, petitioned the U.S. Patent Office to cancel all 58 claims of U.S. Patent No. 8,961,511 owned by the company InMode Ltd.
"We have strong reasons to believe InMode's patent claims are invalid," explainedDavid Chmel, BTL's CEO, "and BTL has asked the United States Patent Office to initiate invalidation proceedings."
For more information about BTL and its medical solutions, please visitwww.bodybybtl.com.
ABOUT BTL
Founded in 1993, BTL has grown to become one of the world's leading medical and aesthetic equipment manufacturers. With over 3,500 employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT NEO®, EMFACE®, EMSCULPT®, EMSELLA®, EMTONE®, EMFEMME 360™, EXION™, and Core to Floor®, as well as their proprietary HIFEM®and HIFES™. Please visitwww.bodybybtl.comfor additional information.
/PRNEWSWIRE/
April 9, 2024
BTL Industries, a renowned leader in cutting-edge medical technologies, is excited to announce its participation in the upcoming American Society for Laser Medicine and Surgery (ASLMS) Conference, taking place fromApril 11 to April 14, 2024, inBaltimore, Maryland. This prestigious event brings together top experts, researchers, and practitioners in the field of medical laser applications and energy-based treatments.
BTL Industries is set to unveil its latest advancements in aesthetic and muscle enhancement at ASLMS, redefining possibilities for enhancing both form and function. With a commitment to innovation and excellence, BTL Industries continues to pave the way for transformative outcomes in medical technology, empowering healthcare professionals to deliver unparalleled solutions for diverse patient needs.
Highlighted below are the presentations featuring BTL Industries' groundbreaking products and technologies:
EMFACE
- Five oral presentations
- Topics include tackling challengingsubmentum cases with Emface, combination technique for Botulinum toxins and Emface treatments, histologic and clinical evaluation of Emface on submentum, facial rejuvenation and volumization with Emface, and facial lifting in Asian population
- E-Poster on the combination of injectables and Emface
EMSCULPT NEO
- Three oral presentations
- Topics include core strength in moms and seniors, muscle stimulation for functional enhancement, and obtaining an hourglass figurenoninvasively
EMSELLA
- Oral presentation
- Topics include enhancing the quality of life in elderly men withpost-prostatectomy incontinence.
Commenting on BTL Industries' leadership position in muscle stimulation technologies for enhancing both form and function,Rohit Mishra, Director of Product Management at BTL Industries, stated: "We are proud to lead the way in advancing the application of muscle stimulation techniques for optimizing both appearance and quality of life. Our commitment to research and development enables us to continuously push the boundaries of innovation, providing healthcare professionals with unparalleled tools to enhance patient outcomes and satisfaction."
BTL Industries looks forward to engaging with attendees, sharing insights, and fostering collaboration to drive further advancements in medical laser technology and energy-based therapies.
The American Society for Laser Medicine and Surgery Inc. (ASLMS) has the ultimate responsibility for the planning, development and content of continuing education programs and presentations, including those highlighted above. BTL did not direct content or influence the planning or implementation of the ASLMS 43rdAnnual Conference. The spontaneous opinions expressed by speakers and participants during these activities belong to those individuals.
About BTL Industries:
Founded in 1993, BTL has grown to become one of the world's leading medical and aesthetic equipment manufacturers. With over 3,500 employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT NEO®, EMFACE®, EMSCULPT®, EMSELLA®, EMTONE®, EMFEMME 360™, EXION™, and Core to Floor®, as well as their proprietary HIFEM®and HIFES™. Please visitwww.bodybybtl.comfor additional information.
/PRNEWSWIRE/
January 18, 2024
In a grand celebration of its most successful year,BTL, a pioneer in the medical aesthetics industry, hosted its largest national sales meeting yet. This marked a significant milestone for the company, having reached a record revenue of680 million USDin 2023. The event was not just a commemoration of past achievements but also a stage for groundbreaking innovations. The spotlight was on the introduction of the new EMFACE Submentum applicator, a device poised to revolutionize the treatment of double chins.
BTL's technological prowess is long-established, and this addition to the EMFACE platform represents a new flagship in BTL's journey. Harnessing the power of patented Synchronized RF+ and HIFES™ technology for facial muscle stimulation, the EMFACE stands as the most innovative non-invasive procedure in the industry.
David Chmel, BTL's CEO, expressed his vision and confidence in the new product. "EMFACE is not just an innovation for today; it lays the foundation for future advancements. By focusing on new treatment areas, we ensure that our technological advancements continue to add value for our customers and redefine the industry."
Designed to prioritize patient comfort, the EMFACE Submentum applicator offers a needle-free and bruise-free treatment. Its noninvasive technology uniquely targets layers from skin to muscle, enhancing the aesthetic appearance with unprecedented precision and ease.
Jennifer Levine, MD, a renownedNew York City-based facial plastic surgeon, shared her enthusiasm for EMFACE's potential. "The EMFACE represents a revolution in double-chin treatments. We now have the ability to target the deeper structures non-invasively in a safe and effective manner."
For more information about the Emface applicator and other innovative products from BTL, please visit emface.com.
About BTL:
Founded in 1993, BTL has grown to become one of the world's leading medical and aesthetic equipment manufacturers. With over 3,000 employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT NEO®, EMFACE®, EMSCULPT®, EMSELLA®, EMTONE®, EMFEMME 360™, EXION™, and Core to Floor®, as well as their proprietary HIFEM®and HIFES™. Please visitwww.bodybybtl.comfor additional information.
